circRNA basic information
circBase ID: hsa_circ_0001492
Name: hsa_circ_ERBB2IP
Synonym: -
Host Gene: ERBB2IP
Genomic location(hg19): chr5:65284462-65290692:+
Genomic location(hg38): chr5:65988634-65994864:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005061
MONDO name: lung adenocarcinoma
Disease details: lung adenocarcinoma / LUAD
Disease DO ID:
3910
Disease MeSH ID:
C538231
Disease NCIt ID:
C3512
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

lung tumor samples; paraneoplastic tissue

Cell lines:

PC9; H1975; BEAS-2B

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: OCIAD2
Associated microRNA: miR-145-5p
Biological function: promotes LUAD cell migration, proliferation, and sphere-forming ability; promotes xenograft tumor growth
Molecular mechanism: acts as a miR-145-5p sponge to increase OCIAD2 expression (ceRNA mechanism)
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); stemness (promotes); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; RNase R Treatment; Sanger Sequencing; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; RNA Pull-Down; Transfection; EdU Staining; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot; Clinical Sample Validation; Bioinformatics Analysis

Clinical significance:

could be a useful target for the diagnosis and treatment of LUAD

Description:

hsa_circ_0001492 is up-regulated in LUAD tissues/cells and mainly localizes to the cytoplasm. It promotes LUAD proliferation, migration, invasion and sphere formation by sponging miR-145-5p to de-repress OCIAD2, and its silencing inhibits xenograft tumor growth.

Confidence score:

0.8439

Other information
Title:

Hsa_circ_0001492 regulates the hsa-miR-145-5p/ovarian carcinoma immunoreactive antigen domain 2 axis to promote the progression of lung adenocarcinoma.

Journal: Biomolecules & biomedicine
Published: 2025
PubMed ID: 39466086
Study type:

combined biological and clinical study

Data availability: The data supporting the findings of this study can be obtained from the corresponding author, upon request.
Code availability: -